{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:01:58Z","timestamp":1784286118455,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Development Fund of Affiliated Hospital of Xuzhou Medical University","award":["XYFY202221"],"award-info":[{"award-number":["XYFY202221"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH058"],"award-info":[{"award-number":["ZR2022MH058"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH119"],"award-info":[{"award-number":["ZR2022MH119"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["2019WS133"],"award-info":[{"award-number":["2019WS133"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2020M672105"],"award-info":[{"award-number":["2020M672105"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00277-023-05247-w","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:01:47Z","timestamp":1683367307000},"page":"1845-1856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RNA-seq analysis reveals candidate genes associated with proliferation, invasion, and migration in BCL11A knockdown B-NHL cell lines"],"prefix":"10.1007","volume":"102","author":[{"given":"Jiawei","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"issue":"11","key":"5247_CR1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.trecan.2020.06.003","volume":"6","author":"EEE Drees","year":"2020","unstructured":"Drees EEE, Pegtel DM (2020) Circulating miRNAs as biomarkers in aggressive B cell lymphomas. Trends Cancer 6(11):910\u2013923. https:\/\/doi.org\/10.1016\/j.trecan.2020.06.003","journal-title":"Trends Cancer"},{"issue":"4","key":"5247_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/bjh.15224","volume":"181","author":"AJ Olszewski","year":"2018","unstructured":"Olszewski AJ, Ollila T, Reagan JL (2018) Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas. Br J Haematol 181(4):495\u2013504. https:\/\/doi.org\/10.1111\/bjh.15224","journal-title":"Br J Haematol"},{"key":"5247_CR3","doi-asserted-by":"publisher","first-page":"302570","DOI":"10.1155\/2012\/302570","volume":"2012","author":"KA Foon","year":"2012","unstructured":"Foon KA, Takeshita K, Zinzani PL (2012) Novel therapies for aggressive B-cell lymphoma. Adv Hematol 2012:302570. https:\/\/doi.org\/10.1155\/2012\/302570","journal-title":"Adv Hematol"},{"key":"5247_CR4","doi-asserted-by":"publisher","first-page":"100822","DOI":"10.1016\/j.drup.2022.100822","volume":"61","author":"M Pi","year":"2022","unstructured":"Pi M, Kuang H, Yue C, Yang Q, Wu A, Li Y, Assaraf YG, Yang DH, Wu S (2022) Targeting metabolism to overcome cancer drug resistance: a promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resist Updat 61:100822. https:\/\/doi.org\/10.1016\/j.drup.2022.100822","journal-title":"Drug Resist Updat"},{"issue":"4","key":"5247_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/cancers14040860","volume":"14","author":"N Profitos-Peleja","year":"2022","unstructured":"Profitos-Peleja N, Santos JC, Marin-Niebla A, Roue G, Ribeiro ML (2022) Regulation of B-cell receptor signaling and its therapeutic relevance in aggressive B-cell lymphomas. Cancers (Basel) 14(4):860. https:\/\/doi.org\/10.3390\/cancers14040860","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5247_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41419-018-1259-5","volume":"10","author":"X Ge","year":"2018","unstructured":"Ge X, Chen J, Li L, Ding P, Wang Q, Zhang W, Li L, Lv X, Zhou D, Jiang Z, Zeng H, Xu Y, Hou Y, Hu W (2018) Midostaurin potentiates rituximab antitumor activity in Burkitt\u2019s lymphoma by inducing apoptosis. Cell Death Dis 10(1):8. https:\/\/doi.org\/10.1038\/s41419-018-1259-5","journal-title":"Cell Death Dis"},{"issue":"13","key":"5247_CR7","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1084\/jem.20121846","volume":"209","author":"Y Yu","year":"2012","unstructured":"Yu Y, Wang J, Khaled W, Burke S, Li P, Chen X, Yang W, Jenkins NA, Copeland NG, Zhang S, Liu P (2012) Bcl11a is essential for lymphoid development and negatively regulates p53. J Exp Med 209(13):2467\u20132483. https:\/\/doi.org\/10.1084\/jem.20121846","journal-title":"J Exp Med"},{"key":"5247_CR8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004558","author":"Y Sunami","year":"2021","unstructured":"Sunami Y, Yokoyama T, Yoshino S, Takahara T, Yamazaki Y, Harada H, Nakamura T (2021) BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2021004558","journal-title":"Blood Adv"},{"key":"5247_CR9","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1038\/ncomms6987","volume":"6","author":"WT Khaled","year":"2015","unstructured":"Khaled WT, Choon Lee S, Stingl J, Chen X, Raza Ali H, Rueda OM, Hadi F, Wang J, Yu Y, Chin SF, Stratton M, Futreal A, Jenkins NA, Aparicio S, Copeland NG, Watson CJ, Caldas C, Liu P (2015) BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells. Nat Commun 6:5987. https:\/\/doi.org\/10.1038\/ncomms6987","journal-title":"Nat Commun"},{"issue":"4","key":"5247_CR10","doi-asserted-by":"publisher","first-page":"1602149","DOI":"10.1183\/13993003.02149-2016","volume":"49","author":"Q Tian","year":"2017","unstructured":"Tian Q, Deng WJ, Li ZW (2017) Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient. Eur Respir J 49(4):1602149. https:\/\/doi.org\/10.1183\/13993003.02149-2016","journal-title":"Eur Respir J"},{"key":"5247_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3389\/fphar.2020.00820","volume":"11","author":"H Shi","year":"2020","unstructured":"Shi H, Li C, Feng W, Yue J, Song J, Peng A, Wang H (2020) BCL11A is oncogenic and predicts poor outcomes in natural killer\/T-cell lymphoma. Front Pharmacol 11:820. https:\/\/doi.org\/10.3389\/fphar.2020.00820","journal-title":"Front Pharmacol"},{"issue":"12","key":"5247_CR12","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1182\/blood.v98.12.3413","volume":"98","author":"E Satterwhite","year":"2001","unstructured":"Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW, Dyer MJ (2001) The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98(12):3413\u20133420. https:\/\/doi.org\/10.1182\/blood.v98.12.3413","journal-title":"Blood"},{"issue":"10","key":"5247_CR13","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/sj.leu.2404324","volume":"20","author":"MA Weniger","year":"2006","unstructured":"Weniger MA, Pulford K, Gesk S, Ehrlich S, Banham AH, Lyne L, Martin-Subero JI, Siebert R, Dyer MJ, Moller P, Barth TF (2006) Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia 20(10):1880\u20131882. https:\/\/doi.org\/10.1038\/sj.leu.2404324","journal-title":"Leukemia"},{"issue":"9","key":"5247_CR14","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/labinvest.3700152","volume":"84","author":"WJ Luo","year":"2004","unstructured":"Luo WJ, Takakuwa T, Ham MF, Wada N, Liu A, Fujita S, Sakane-Ishikawa E, Aozasa K (2004) Epstein-Barr virus is integrated between REL and BCL-11A in American Burkitt lymphoma cell line (NAB-2). Lab Invest 84(9):1193\u20131199. https:\/\/doi.org\/10.1038\/labinvest.3700152","journal-title":"Lab Invest"},{"issue":"12","key":"5247_CR15","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1158\/0008-5472.CAN-18-3438","volume":"79","author":"J Hullein","year":"2019","unstructured":"Hullein J, Slabicki M, Rosolowski M, Jethwa A, Habringer S, Tomska K, Kurilov R, Lu J, Scheinost S, Wagener R, Huang Z, Lukas M, Yavorska O, Helfrich H, Scholtysik R, Bonneau K, Tedesco D, Kuppers R, Klapper W, Pott C, Stilgenbauer S, Burkhardt B, Loffler M, Trumper LH, Hummel M, Brors B, Zapatka M, Siebert R, Kreuz M, Keller U, Huber W, Zenz T (2019) MDM4 is targeted by 1q gain and drives disease in Burkitt lymphoma. Cancer Res 79(12):3125\u20133138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3438","journal-title":"Cancer Res"},{"issue":"2","key":"5247_CR16","doi-asserted-by":"publisher","first-page":"101042831990106","DOI":"10.1177\/1010428319901061","volume":"42","author":"P Virdis","year":"2020","unstructured":"Virdis P, Migheli R, Galleri G, Fancello S, Cadoni MPL, Pintore G, Petretto GL, Marchesi I, Fiorentino FP, di Francesco A, Sanges F, Bagella L, Muroni MR, Fozza C, De Miglio MR, Podda L (2020) Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. Tumour Biol 42(2):1010428319901061. https:\/\/doi.org\/10.1177\/1010428319901061","journal-title":"Tumour Biol"},{"key":"5247_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/2047-783X-19-34","volume":"19","author":"D He","year":"2014","unstructured":"He D, Wu H, Ding L, Li Y (2014) Combination of BCL11A siRNA with vincristine increases the apoptosis of SUDHL6 cells. Eur J Med Res 19:34. https:\/\/doi.org\/10.1186\/2047-783X-19-34","journal-title":"Eur J Med Res"},{"key":"5247_CR18","doi-asserted-by":"publisher","first-page":"656045","DOI":"10.3389\/fonc.2021.656045","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xiang J, Zhu N, Ge H, Sheng X, Deng S, Chen J, Yu L, Zhou Y, Shen J (2021) Curcumin in combination with omacetaxine suppress lymphoma cell growth, migration, invasion, and angiogenesis via inhibition of VEGF\/Akt signaling pathway. Front Oncol 11:656045. https:\/\/doi.org\/10.3389\/fonc.2021.656045","journal-title":"Front Oncol"},{"issue":"16","key":"5247_CR19","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1111\/febs.15216","volume":"287","author":"IC Navarro-Hernandez","year":"2020","unstructured":"Navarro-Hernandez IC, Lopez-Ortega O, Acevedo-Ochoa E, Cervantes-Diaz R, Romero-Ramirez S, Sosa-Hernandez VA, Meza-Sanchez DE, Juarez-Vega G, Perez-Martinez CA, Chavez-Munguia B, Galvan-Hernandez A, Antillon A, Ortega-Blake I, Santos-Argumedo L, Hernandez-Hernandez JM, Maravillas-Montero JL (2020) Tetraspanin 33 (TSPAN33) regulates endocytosis and migration of human B lymphocytes by affecting the tension of the plasma membrane. FEBS J 287(16):3449\u20133471. https:\/\/doi.org\/10.1111\/febs.15216","journal-title":"FEBS J"},{"issue":"2","key":"5247_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","volume":"173","author":"N Liu","year":"2018","unstructured":"Liu N, Hargreaves VV, Zhu Q, Kurland JV, Hong J, Kim W, Sher F, Macias-Trevino C, Rogers JM, Kurita R, Nakamura Y, Yuan GC, Bauer DE, Xu J, Bulyk ML, Orkin SH (2018) Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch. Cell 173(2):430-442 e417. https:\/\/doi.org\/10.1016\/j.cell.2018.03.016","journal-title":"Cell"},{"issue":"6","key":"5247_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ni925","volume":"4","author":"P Liu","year":"2003","unstructured":"Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG (2003) Bcl11a is essential for normal lymphoid development. Nat Immunol 4(6):525\u2013532. https:\/\/doi.org\/10.1038\/ni925","journal-title":"Nat Immunol"},{"issue":"19","key":"5247_CR22","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1182\/blood-2010-04-281428","volume":"119","author":"RJ Bergerson","year":"2012","unstructured":"Bergerson RJ, Collier LS, Sarver AL, Been RA, Lugthart S, Diers MD, Zuber J, Rappaport AR, Nixon MJ, Silverstein KA, Fan D, Lamblin AF, Wolff L, Kersey JH, Delwel R, Lowe SW, O\u2019Sullivan MG, Kogan SC, Adams DJ, Largaespada DA (2012) An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Blood 119(19):4512\u20134523. https:\/\/doi.org\/10.1182\/blood-2010-04-281428","journal-title":"Blood"},{"issue":"5","key":"5247_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1182\/blood-2008-03-144436","volume":"113","author":"B Yin","year":"2009","unstructured":"Yin B, Delwel R, Valk PJ, Wallace MR, Loh ML, Shannon KM, Largaespada DA (2009) A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood 113(5):1075\u20131085. https:\/\/doi.org\/10.1182\/blood-2008-03-144436","journal-title":"Blood"},{"key":"5247_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.leukres.2016.05.018","volume":"47","author":"J Yin","year":"2016","unstructured":"Yin J, Zhang F, Tao H, Ma X, Su G, Xie X, Xu Z, Zheng Y, Liu H, He C, Mao ZJ, Wang Z, Chang W, Gale RP, Wu D, Yin B (2016) BCL11A expression in acute phase chronic myeloid leukemia. Leuk Res 47:88\u201392. https:\/\/doi.org\/10.1016\/j.leukres.2016.05.018","journal-title":"Leuk Res"},{"key":"5247_CR25","doi-asserted-by":"publisher","first-page":"755188","DOI":"10.3389\/fonc.2021.755188","volume":"11","author":"LL Wang","year":"2021","unstructured":"Wang LL, Yan D, Tang X, Zhang M, Liu S, Wang Y, Zhang M, Zhou G, Li T, Jiang F, Chen X, Wen F, Liu S, Mai H (2021) High expression of BCL11A predicts poor prognosis for childhood MLL-r ALL. Front Oncol 11:755188. https:\/\/doi.org\/10.3389\/fonc.2021.755188","journal-title":"Front Oncol"},{"issue":"8","key":"5247_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ajh.21758","volume":"85","author":"C Agueli","year":"2010","unstructured":"Agueli C, Cammarata G, Salemi D, Dagnino L, Nicoletti R, La Rosa M, Messana F, Marfia A, Bica MG, Coniglio ML, Pagano M, Fabbiano F, Santoro A (2010) 14q32\/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a. Am J Hematol 85(8):575\u2013578. https:\/\/doi.org\/10.1002\/ajh.21758","journal-title":"Am J Hematol"},{"issue":"2","key":"5247_CR27","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1111\/ajco.12690","volume":"14","author":"L Xu","year":"2018","unstructured":"Xu L, Wu H, Wu X, Li Y, He D (2018) The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia. Asia Pac J Clin Oncol 14(2):e124\u2013e128. https:\/\/doi.org\/10.1111\/ajco.12690","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"5247_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ijlh.13969","volume":"45","author":"N Tosic","year":"2023","unstructured":"Tosic N, Ugrin M, Marjanovic I, Kostic T, Vukovic V, Tomic K, Otasevic V, Antic D, Mihaljevic B, Pavlovic S, Karan-Djurasevic T (2023) Expression of BCL11A in chronic lymphocytic leukaemia. Int J Lab Hematol 45(1):64\u201371. https:\/\/doi.org\/10.1111\/ijlh.13969","journal-title":"Int J Lab Hematol"},{"issue":"17","key":"5247_CR29","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1200\/JCO.2004.11.025","volume":"22","author":"S Bea","year":"2004","unstructured":"Bea S, Colomo L, Lopez-Guillermo A, Salaverria I, Puig X, Pinyol M, Rives S, Montserrat E, Campo E (2004) Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol 22(17):3498\u20133506. https:\/\/doi.org\/10.1200\/JCO.2004.11.025","journal-title":"J Clin Oncol"},{"issue":"9","key":"5247_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/gcc.22184","volume":"53","author":"A Kwiecinska","year":"2014","unstructured":"Kwiecinska A, Ichimura K, Berglund M, Dinets A, Sulaiman L, Collins VP, Larsson C, Porwit A, Lagercrantz SB (2014) Amplification of 2p as a genomic marker for transformation in lymphoma. Genes Chromosom Cancer 53(9):750\u2013768. https:\/\/doi.org\/10.1002\/gcc.22184","journal-title":"Genes Chromosom Cancer"},{"key":"5247_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fonc.2020.00375","volume":"10","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou L, Zhang D, Tang WJ, Tang D, Shi XL, Yang Y, Zhou L, Liu F, Yu Y, Liu P, Tao L, Lu LM (2020) BCL11A promotes the progression of laryngeal squamous cell carcinoma. Front Oncol 10:375. https:\/\/doi.org\/10.3389\/fonc.2020.00375","journal-title":"Front Oncol"},{"issue":"33","key":"5247_CR32","doi-asserted-by":"publisher","first-page":"11707","DOI":"10.1074\/jbc.RA120.014018","volume":"295","author":"DD Seachrist","year":"2020","unstructured":"Seachrist DD, Hannigan MM, Ingles NN, Webb BM, Weber-Bonk KL, Yu P, Bebek G, Singh S, Sizemore ST, Varadan V, Licatalosi DD, Keri RA (2020) The transcriptional repressor BCL11A promotes breast cancer metastasis. J Biol Chem 295(33):11707\u201311719. https:\/\/doi.org\/10.1074\/jbc.RA120.014018","journal-title":"J Biol Chem"},{"issue":"1","key":"5247_CR33","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1038\/s41467-018-05790-5","volume":"9","author":"KA Lazarus","year":"2018","unstructured":"Lazarus KA, Hadi F, Zambon E, Bach K, Santolla MF, Watson JK, Correia LL, Das M, Ugur R, Pensa S, Becker L, Campos LS, Ladds G, Liu P, Evan GI, McCaughan FM, Le Quesne J, Lee JH, Calado D, Khaled WT (2018) BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma. Nat Commun 9(1):3327. https:\/\/doi.org\/10.1038\/s41467-018-05790-5","journal-title":"Nat Commun"},{"issue":"4","key":"5247_CR34","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3892\/or.2016.5018","volume":"36","author":"X Zhang","year":"2016","unstructured":"Zhang X, Wang L, Wang Y, Shi S, Zhu H, Xiao F, Yang J, Yang A, Hao X (2016) Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A\/MDM2 expression. Oncol Rep 36(4):2349\u20132356. https:\/\/doi.org\/10.3892\/or.2016.5018","journal-title":"Oncol Rep"},{"issue":"9","key":"5247_CR35","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1128\/MCB.20.9.3178-3186.2000","volume":"20","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA, Copeland NG (2000) Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product. Mol Cell Biol 20(9):3178\u20133186. https:\/\/doi.org\/10.1128\/MCB.20.9.3178-3186.2000","journal-title":"Mol Cell Biol"},{"issue":"4","key":"5247_CR36","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.3892\/ol.2020.11383","volume":"19","author":"X Wang","year":"2020","unstructured":"Wang X, Xu Y, Xu K, Chen Y, Xiao X, Guan X (2020) BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer. Oncol Lett 19(4):2916\u20132924. https:\/\/doi.org\/10.3892\/ol.2020.11383","journal-title":"Oncol Lett"},{"issue":"3","key":"5247_CR37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.26355\/eurrev_201902_16998","volume":"23","author":"J Liao","year":"2019","unstructured":"Liao J, Xie N (2019) Long noncoding RNA DSCAM-AS1 functions as an oncogene in non-small cell lung cancer by targeting BCL11A. Eur Rev Med Pharmacol Sci 23(3):1087\u20131092. https:\/\/doi.org\/10.26355\/eurrev_201902_16998","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"5247_CR38","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3892\/ijo.2020.4995","volume":"56","author":"KJ Zhang","year":"2020","unstructured":"Zhang KJ, Hu Y, Luo N, Li X, Chen FY, Yuan JQ, Guo L (2020) miR-574-5p attenuates proliferation, migration and EMT in triple-negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL\/TAZ\/CTGF axis. Int J Oncol 56(5):1240\u20131251. https:\/\/doi.org\/10.3892\/ijo.2020.4995","journal-title":"Int J Oncol"},{"key":"5247_CR39","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.2147\/cmar.S199368","volume":"11","author":"L Zhu","year":"2019","unstructured":"Zhu L, Pan R, Zhou D, Ye G, Tan W (2019) BCL11A enhances stemness and promotes progression by activating Wnt\/\u03b2-catenin signaling in breast cancer. Cancer Manag Res 11:2997\u20133007. https:\/\/doi.org\/10.2147\/cmar.S199368","journal-title":"Cancer Manag Res"},{"issue":"3","key":"5247_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41375-019-0628-0","volume":"34","author":"F Gehringer","year":"2020","unstructured":"Gehringer F, Weissinger SE, M\u00f6ller P, Wirth T, Ushmorov A (2020) Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma. Leukemia 34(3):857\u2013871. https:\/\/doi.org\/10.1038\/s41375-019-0628-0","journal-title":"Leukemia"},{"issue":"7","key":"5247_CR41","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.7150\/thno.41362","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Ge X, Zhang W, Ding P, Du Y, Wang Q, Li L, Fang L, Sun Y, Zhang P, Zhou Y, Zhang L, Lv X, Li L, Zhang X, Zhang Q, Xue K, Gu H, Lei Q, Wong J, Hu W (2020) PI3K\/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma. Theranostics 10(7):3151\u20133163. https:\/\/doi.org\/10.7150\/thno.41362","journal-title":"Theranostics"},{"issue":"52","key":"5247_CR42","doi-asserted-by":"publisher","first-page":"86433","DOI":"10.18632\/oncotarget.13239","volume":"7","author":"HY Park","year":"2016","unstructured":"Park HY, Lee SB, Yoo HY, Kim SJ, Kim WS, Kim JI, Ko YH (2016) Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma. Oncotarget 7(52):86433\u201386445. https:\/\/doi.org\/10.18632\/oncotarget.13239","journal-title":"Oncotarget"},{"key":"5247_CR43","doi-asserted-by":"publisher","DOI":"10.2174\/1568009622666220728123748","author":"Q Jin","year":"2022","unstructured":"Jin Q, Chen Y, Du S, Xu D, Yue J, Cai L, Yuan X (2022) BCL11A facilitates cell proliferation and metastasis in neuroblastoma via regulating the PI3K\/Akt signaling pathway. Curr Cancer Drug Targets. https:\/\/doi.org\/10.2174\/1568009622666220728123748","journal-title":"Curr Cancer Drug Targets"},{"issue":"51","key":"5247_CR44","doi-asserted-by":"publisher","first-page":"88658","DOI":"10.18632\/oncotarget.20809","volume":"8","author":"CH Zhang","year":"2017","unstructured":"Zhang CH, Wang J, Zhang LX, Lu YH, Ji TH, Xu L, Ling LJ (2017) Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57. Oncotarget 8(51):88658\u201388669. https:\/\/doi.org\/10.18632\/oncotarget.20809","journal-title":"Oncotarget"},{"key":"5247_CR45","doi-asserted-by":"publisher","unstructured":"Qian J, LeSavage BL, Hubka KM, Ma C, Natarajan S, Eggold JT, Xiao Y, Fuh KC, Krishnan V, Enejder A, Heilshorn SC, Dorigo O, Rankin EB (2021) Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Investig 131(16):e146186.\u00a0https:\/\/doi.org\/10.1172\/jci146186","DOI":"10.1172\/jci146186"},{"key":"5247_CR46","doi-asserted-by":"publisher","first-page":"5806602","DOI":"10.1155\/2021\/5806602","volume":"2021","author":"X Pang","year":"2021","unstructured":"Pang X, Zhang J, He X, Gu Y, Qian BZ, Xie R, Yu W, Zhang X, Li T, Shi X, Zhou Y, Cui Y (2021) SPP1 promotes enzalutamide resistance and epithelial-mesenchymal-transition activation in castration-resistant prostate cancer via PI3K\/AKT and ERK1\/2 pathways. Oxid Med Cell Longev 2021:5806602. https:\/\/doi.org\/10.1155\/2021\/5806602","journal-title":"Oxid Med Cell Longev"},{"key":"5247_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.canlet.2017.08.022","volume":"408","author":"A Bastos","year":"2017","unstructured":"Bastos A, Blunck CB, Emerenciano M, Gimba ERP (2017) Osteopontin and their roles in hematological malignancies: splice variants on the new avenues. Cancer Lett 408:138\u2013143. https:\/\/doi.org\/10.1016\/j.canlet.2017.08.022","journal-title":"Cancer Lett"},{"key":"5247_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbamcr.2015.09.018","volume":"3","author":"G Malaponte","year":"1863","unstructured":"Malaponte G, Hafsi S, Polesel J, Castellano G, Spessotto P, Guarneri C, Canevari S, Signorelli SS, McCubrey JA (1863) Libra M (2016) Tumor microenvironment in diffuse large B-cell lymphoma: matrixmetalloproteinases activation is mediated by osteopontin overexpression. Biochem Biophys Acta 3:483\u2013489. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.09.018","journal-title":"Biochem Biophys Acta"},{"issue":"12","key":"5247_CR49","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41379-020-0575-3","volume":"33","author":"L Mundo","year":"2020","unstructured":"Mundo L, Del Porro L, Granai M, Siciliano MC, Mancini V, Santi R, Marcar L, Vrzalikova K, Vergoni F, Di Stefano G, Schiavoni G, Segreto G, Onyango N, Nyagol JA, Amato T, Bellan C, Anagnostopoulos I, Falini B, Leoncini L, Tiacci E, Lazzi S (2020) Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas. Mod Pathol 33(12):2407\u20132421. https:\/\/doi.org\/10.1038\/s41379-020-0575-3","journal-title":"Mod Pathol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05247-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T06:04:38Z","timestamp":1686549878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05247-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["5247"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05247-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}